Inotiv Inc. (NOTV) NASDAQ
$5.63 - (-)
Market Cap: $145.20M
As of 04/16/24 03:59 PM EDT. Market closed.
Inotiv Inc. (NOTV)
NASDAQ
$5.63
- (-)
Market Cap: $145.20M
As of 04/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
*we are a cro and lab instrumentation provider* basi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. we provide world-class research to the global pharmaceutical industry. our services include preclinical toxicology, early in vivo pk, bioanalysis and a full range of pharmaceutical analysis services. basi also ... read more
*we are a cro and lab instrumentation provider* basi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. we provide world-class research to the global pharmaceutical industry. our services include preclinical toxicology, early in vivo pk, bioanalysis and a full range of pharmaceutical analysis services. basi also manufactures innovative scientific instruments including the culex® automated in vivo sampling system which can collect blood, bile, microdialysates, activity behavior, telemetry data and more from awake, freely-moving subjects. we are known for our scientific expertise, responsiveness to clients, exemplary regulatory record, and helping our clients meet key milestones on time. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacqueline Lemke
Full Time Employees
212
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacqueline Lemke
Full Time Employees
212
URL
Address
2701 Kent Ave, Indiana, West Lafayette, 47906-1350.
PRICE CHART FOR INOTIV INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.50
Previous Close
$5.63
Days Range
$5.49 - $5.94
52 week range
$1.61 - $11.42
Volume
364,528
Avg. Volume (30 days)
521,872
Market Cap
$145.20M
Dividend Yield
-
P/E
-
Shares Outstanding
25,790,680
Open
$5.50
Previous Close
$5.63
Days Range
$5.49 - $5.94
52 week range
$1.61 - $11.42
Volume
364,528
Avg. Volume (30 days)
521,872
Market Cap
$145.20M
Dividend Yield
-
P/E
-
Shares Outstanding
25,790,680
FINANCIAL STATEMENTS FOR INOTIV INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR INOTIV INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Leasure Robert Jr. | President and CEO | Jun 07, 2019 | Buy | $1.98 | 7,500 | 14,864 | 105,000 | Jan 25, 2024, 04:19 PM |
| Garrett Michael | Chief Commercial Officer | Dec 14, 2023 | Buy | $2.83 | 5,000 | 14,145 | 16,467 | Dec 15, 2023, 05:33 PM |
| Beattie John Gregory | Chief Operating Officer | Dec 14, 2023 | Buy | $3.12 | 47,966 | 149,836 | 111,761 | Dec 15, 2023, 05:33 PM |
| Sagartz John E | Chief Strategy Officer | Mar 14, 2023 | Buy | $4.91 | 5,100 | 25,041 | 692,047 | Mar 16, 2023, 04:03 PM |
| Beattie John Gregory | Chief Operating Officer | Feb 22, 2023 | Buy | $6.99 | 5,000 | 34,950 | 63,795 | Feb 24, 2023, 04:02 PM |
| Pitchford William D | Chief Human Resources Officer | Dec 09, 2022 | Sale | $5.82 | 2,123 | 12,366 | 74,051 | Dec 29, 2022, 07:12 AM |
| Neff R Matthew | Director | Dec 01, 2022 | Sale | $6.12 | 1,000 | 6,120 | 62,388 | Dec 02, 2022, 08:11 PM |
| Neff R Matthew | Director | Nov 01, 2022 | Sale | $21.12 | 1,000 | 21,123 | 63,888 | Nov 03, 2022, 04:13 PM |
| Neff R Matthew | Director | Oct 17, 2022 | Sale | $19.10 | 1,000 | 19,100 | 64,388 | Oct 18, 2022, 05:37 PM |
| Garrett Michael | Chief Commercial Officer | Sep 15, 2022 | Buy | $23.06 | 1,000 | 23,058 | 2,000 | Sep 19, 2022, 04:06 PM |
| Beattie John Gregory | Chief Operating Officer | Sep 09, 2022 | Buy | $22.34 | 8,900 | 198,826 | 51,694 | Sep 13, 2022, 04:04 PM |
| Harkness James | Chief Operating Officer, RMS | Mar 15, 2022 | Buy | $19.65 | 38,968 | 765,637 | 38,968 | Mar 16, 2022, 10:47 AM |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | Feb 22, 2022 | Buy | $23.97 | 2,000 | 47,946 | 42,195 | Feb 23, 2022, 05:22 PM |
| Taylor Beth | VP- Finance & CFO | Feb 18, 2022 | Buy | $23.07 | 5,000 | 115,358 | 83,875 | Feb 22, 2022, 07:54 AM |
| Davis Gregory Cole | Director | Feb 18, 2022 | Buy | $22.99 | 3,750 | 86,214 | 37,683 | Feb 22, 2022, 07:53 AM |
| Davis Gregory Cole | Director | Feb 17, 2022 | Buy | $20.57 | 1,250 | 25,714 | 33,933 | Feb 22, 2022, 07:53 AM |
| Garrett Michael | Chief Commercial Officer | Feb 18, 2022 | Buy | $23.50 | 1,000 | 23,500 | 1,000 | Feb 22, 2022, 07:52 AM |
| Pitchford William D | Chief HR Officer | Feb 18, 2022 | Buy | $21.12 | 3,500 | 73,920 | 76,174 | Feb 18, 2022, 05:49 PM |
| Beattie John Gregory | Chief Operating Officer | Feb 18, 2022 | Buy | $23.88 | 1,000 | 23,879 | 42,794 | Feb 18, 2022, 05:48 PM |
| Beattie John Gregory | Chief Operating Officer | Feb 17, 2022 | Buy | $21.19 | 4,600 | 97,468 | 41,794 | Feb 18, 2022, 05:48 PM |
| Beattie John Gregory | Chief Operating Officer | Feb 16, 2022 | Buy | $23.71 | 5,800 | 137,524 | 37,194 | Feb 18, 2022, 05:48 PM |
| Leasure Robert Jr. | President and CEO | Feb 17, 2022 | Buy | $23.03 | 5,000 | 115,131 | 285,216 | Feb 17, 2022, 09:42 PM |
| Sagartz John E | Chief Strategy Officer | Feb 17, 2022 | Buy | $19.95 | 2,506 | 49,999 | 681,030 | Feb 17, 2022, 05:18 PM |
| Johnson Richard Allen | Director | Aug 02, 2021 | Option Exercise | $1.29 | 25,000 | 32,300 | 67,683 | Feb 07, 2022, 07:43 PM |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | Dec 22, 2021 | Sale | $43.04 | 3,057 | 131,577 | 40,195 | Jan 12, 2022, 04:31 PM |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | Dec 22, 2021 | Sale | $43.04 | 3,057 | 131,577 | 40,195 | Dec 30, 2021, 08:40 PM |
| Sagartz John E | Chief Strategy Officer | May 28, 2021 | Buy | $24.78 | 2,012 | 49,857 | 646,782 | Jun 01, 2021, 04:01 PM |
| Sagartz John E | Chief Strategy Officer | May 27, 2021 | Buy | $24.00 | 5 | 120 | 644,770 | Jun 01, 2021, 04:01 PM |
| Taylor Beth | VP- Finance & CFO | Mar 05, 2021 | Buy | $17.70 | 5,000 | 88,500 | 34,295 | Mar 05, 2021, 04:41 PM |
| Beattie John Gregory | Chief Operating Officer | Mar 01, 2021 | Buy | $18.60 | 1,712 | 31,843 | 25,000 | Mar 01, 2021, 04:14 PM |
| Beattie John Gregory | Chief Operating Officer | Feb 23, 2021 | Buy | $14.00 | 8,288 | 116,032 | 23,288 | Feb 25, 2021, 04:03 PM |
| Leasure Robert Jr. | President and CEO | Feb 24, 2021 | Buy | $14.42 | 5,000 | 72,100 | 5,000 | Feb 24, 2021, 04:29 PM |
| Neff R Matthew | Director | Mar 13, 2020 | Buy | $3.93 | 3,350 | 13,166 | 43,430 | Jan 12, 2021, 04:41 PM |
| Neff R Matthew | Director | Mar 12, 2020 | Buy | $3.80 | 8,497 | 32,289 | 40,080 | Jan 12, 2021, 04:41 PM |
| Neff R Matthew | Director | Feb 20, 2020 | Buy | $4.60 | 9,458 | 43,507 | 31,583 | Jan 12, 2021, 04:34 PM |
| Sagartz John E | Chief Strategy Officer | Aug 19, 2020 | Buy | $4.75 | 3,733 | 17,732 | 634,232 | Aug 20, 2020, 04:02 PM |
| Neff R Matthew | Director | Aug 19, 2020 | Buy | $4.75 | 5,000 | 23,750 | 60,350 | Aug 19, 2020, 04:27 PM |
| Leasure Robert Jr. | President and CEO | Jun 15, 2020 | Buy | $5.20 | 2,884 | 14,997 | 186,549 | Jun 16, 2020, 04:08 PM |
| Pitchford William D | Chief HR Officer | May 21, 2020 | Buy | $4.47 | 10,000 | 44,700 | 32,000 | May 22, 2020, 04:02 PM |
| Taylor Beth | VP- Finance & CFO | May 21, 2020 | Buy | $4.52 | 3,300 | 14,916 | 13,300 | May 21, 2020, 07:13 PM |
| Taylor Beth | VP- Finance & CFO | May 20, 2020 | Buy | $4.42 | 4,933 | 21,804 | 10,000 | May 21, 2020, 07:13 PM |
| Taylor Beth | VP- Finance & CFO | May 19, 2020 | Buy | $4.38 | 5,067 | 22,193 | 5,067 | May 21, 2020, 07:13 PM |
| Leasure Robert Jr. | President and CEO | Mar 16, 2020 | Buy | $3.49 | 5,700 | 19,893 | 183,665 | Mar 17, 2020, 04:01 PM |
| Neff R Matthew | Director | Mar 13, 2020 | Buy | $3.93 | 3,350 | 13,166 | 45,350 | Mar 16, 2020, 04:04 PM |
| Neff R Matthew | Director | Mar 12, 2020 | Buy | $3.80 | 12,000 | 45,600 | 42,000 | Mar 16, 2020, 04:04 PM |
| Neff R Matthew | Director | Feb 20, 2020 | Buy | $4.60 | 9,458 | 43,507 | 30,000 | Feb 21, 2020, 04:03 PM |
| Johnson Richard Allen | Director | Feb 20, 2020 | Buy | $4.63 | 20,000 | 92,600 | 30,000 | Feb 20, 2020, 04:06 PM |
| Leasure Robert Jr. | President and CEO | Sep 13, 2019 | Buy | $3.72 | 26,846 | 99,867 | 164,965 | Sep 16, 2019, 04:08 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Sep 13, 2019 | Buy | $3.65 | 1,000 | 3,650 | 48,546 | Sep 16, 2019, 04:08 PM |
| Pitchford William D | Chief HR Officer | Sep 13, 2019 | Buy | $3.70 | 12,000 | 44,400 | 22,000 | Sep 16, 2019, 04:07 PM |
| Perrow Wendy | Director | Sep 10, 2019 | Buy | $3.62 | 10,000 | 36,200 | 10,000 | Sep 11, 2019, 04:18 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Sep 06, 2019 | Buy | $3.35 | 2,000 | 6,700 | 47,546 | Sep 06, 2019, 04:01 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Sep 05, 2019 | Buy | $3.45 | 10,500 | 36,225 | 45,546 | Sep 06, 2019, 04:01 PM |
| Leasure Robert Jr. | President and CEO | Sep 04, 2019 | Buy | $3.15 | 11,500 | 36,225 | 138,119 | Sep 05, 2019, 04:13 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Aug 29, 2019 | Buy | $2.69 | 5,000 | 13,450 | 36,046 | Sep 03, 2019, 04:21 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Aug 23, 2019 | Buy | $2.77 | 2,594 | 7,185 | 31,046 | Aug 26, 2019, 04:18 PM |
| Leasure Robert Jr. | President and CEO | Aug 19, 2019 | Buy | $2.19 | 16,000 | 35,040 | 126,619 | Aug 20, 2019, 04:08 PM |
| Neff R Matthew | Director | Jun 13, 2019 | Buy | $1.98 | 1,410 | 2,792 | 22,125 | Jun 14, 2019, 04:33 PM |
| Leasure Robert Jr. | President and CEO | Jun 12, 2019 | Buy | $1.94 | 4 | 8 | 105,619 | Jun 14, 2019, 04:33 PM |
| Leasure Robert Jr. | President and CEO | Jun 13, 2019 | Buy | $1.97 | 5,000 | 9,850 | 110,619 | Jun 14, 2019, 04:33 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Jun 14, 2019 | Buy | $1.99 | 7,500 | 14,925 | 28,452 | Jun 14, 2019, 04:32 PM |
| Blumhoff Jill | VP, Finance & CFO | Jun 11, 2019 | Buy | $1.98 | 500 | 990 | 1,811 | Jun 13, 2019, 05:25 PM |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | Jun 10, 2019 | Buy | $1.96 | 5,000 | 9,800 | 25,765 | Jun 11, 2019, 04:04 PM |
| Leasure Robert Jr. | President and CEO | Jun 07, 2019 | Buy | $1.96 | 5,000 | 9,800 | 105,615 | Jun 10, 2019, 05:00 PM |
| Leasure Robert Jr. | President and CEO | Jun 06, 2019 | Buy | $1.95 | 1,000 | 1,950 | 100,615 | Jun 10, 2019, 05:00 PM |
| Davis Gregory Cole | Director | May 29, 2019 | Buy | $1.99 | 5,000 | 9,950 | 10,000 | May 31, 2019, 04:02 PM |
| Davis Gregory Cole | Director | May 31, 2019 | Buy | $2.00 | 5,000 | 10,000 | 20,000 | May 31, 2019, 04:02 PM |
| Davis Gregory Cole | Director | May 30, 2019 | Buy | $1.96 | 5,000 | 9,800 | 15,000 | May 31, 2019, 04:02 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Mar 15, 2019 | Buy | $1.90 | 1 | 2 | 20,952 | Mar 19, 2019, 04:21 PM |
| Sagartz John E | Director | Mar 14, 2019 | Buy | $1.94 | 1,400 | 2,716 | 3,900 | Mar 14, 2019, 04:16 PM |
| Leasure Robert Jr. | President and CEO | Mar 12, 2019 | Buy | $1.94 | 6,000 | 11,640 | 99,615 | Mar 14, 2019, 04:08 PM |
| Leasure Robert Jr. | President and CEO | Mar 08, 2019 | Buy | $1.77 | 4,000 | 7,080 | 93,615 | Mar 11, 2019, 04:10 PM |
| Neff R Matthew | Director | Mar 08, 2019 | Buy | $1.75 | 5,715 | 10,001 | 20,715 | Mar 11, 2019, 04:09 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Mar 06, 2019 | Buy | $1.75 | 10,000 | 17,500 | 20,951 | Mar 07, 2019, 04:17 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Mar 01, 2019 | Buy | $1.54 | 125 | 192 | 10,951 | Mar 05, 2019, 04:34 PM |
| Sagartz John E | Director | Feb 19, 2019 | Option Exercise | $1.43 | 2,500 | 3,575 | 2,500 | Mar 01, 2019, 05:16 PM |
| Leasure Robert Jr. | President and CEO | Mar 01, 2019 | Buy | $1.62 | 10,000 | 16,200 | 89,615 | Mar 01, 2019, 05:12 PM |
| Leasure Robert Jr. | President and CEO | Feb 28, 2019 | Buy | $1.51 | 8,900 | 13,439 | 79,615 | Mar 01, 2019, 05:12 PM |
| Oakley Daniel Thomas | Chief Operating Officer | Feb 27, 2019 | Buy | $1.53 | 10,826 | 16,564 | 10,826 | Feb 28, 2019, 05:15 PM |
| KISSINGER PETER | 10% Owner | Sep 14, 2018 | Buy | $1.74 | 10,000 | 17,382 | 1,033,457 | Sep 18, 2018, 09:50 PM |
| Neff R Matthew | Director | Sep 12, 2018 | Option Exercise | $1.65 | 2,500 | 4,125 | 12,500 | Sep 18, 2018, 04:09 PM |
| Neff R Matthew | Director | Sep 14, 2018 | Buy | $1.66 | 2,500 | 4,150 | 15,000 | Sep 18, 2018, 04:09 PM |
| Blumhoff Jill | VP, Finance & CFO | Sep 13, 2018 | Option Exercise | $1.62 | 450 | 729 | 1,311 | Sep 18, 2018, 04:09 PM |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | Sep 11, 2018 | Buy | $1.67 | 5,000 | 8,350 | 20,765 | Sep 12, 2018, 12:00 AM |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | Feb 16, 2018 | Buy | $1.46 | 5,000 | 7,300 | 15,765 | Feb 20, 2018, 04:17 PM |
| Neff R Matthew | Director | Sep 08, 2017 | Buy | $1.50 | 5,000 | 7,500 | 10,000 | Sep 08, 2017, 04:16 PM |
| Davis Gregory Cole | Director | Aug 18, 2017 | Buy | $1.70 | 5,000 | 8,500 | 5,000 | Aug 23, 2017, 10:23 AM |
| Neff R Matthew | Director | Aug 18, 2017 | Buy | $1.70 | 5,000 | 8,500 | 5,000 | Aug 23, 2017, 10:23 AM |
| Blumhoff Jill | VP, Finance & CFO | Mar 15, 2017 | Option Exercise | $1.66 | 1,639 | 2,721 | 861 | Mar 17, 2017, 04:36 PM |
| Blumhoff Jill | VP, Finance & CFO | Mar 15, 2017 | Option Exercise | $1.09 | 2,500 | 2,720 | 2,000 | Mar 17, 2017, 04:36 PM |
| Downing Philip A | VP, Preclinical Srvcs. | Mar 01, 2017 | Option Exercise | $1.62 | 6,235 | 10,101 | 10,765 | Mar 15, 2017, 05:39 PM |
| Downing Philip A | VP, Preclinical Srvcs. | Mar 01, 2017 | Option Exercise | $1.01 | 10,000 | 10,100 | 17,000 | Mar 15, 2017, 05:39 PM |
| Dougherty Connie Leigh | VP, Business Development | May 27, 2016 | Buy | $0.92 | 423 | 389 | 9,074 | May 27, 2016, 04:05 PM |
| Dougherty Connie Leigh | VP, Business Development | May 23, 2016 | Buy | $0.92 | 96 | 88 | 8,651 | May 25, 2016, 04:51 PM |
| Dougherty Connie Leigh | VP, Business Development | May 19, 2016 | Buy | $0.92 | 1,655 | 1,523 | 8,555 | May 23, 2016, 04:29 PM |
| Lemke Jacqueline M | President and CEO | Feb 29, 2016 | Buy | $1.17 | 6,000 | 7,020 | 9,000 | Mar 02, 2016, 05:04 PM |
| Lemke Jacqueline M | President and CEO | Feb 29, 2016 | Buy | $1.19 | 4,000 | 4,742 | 60,685 | Mar 02, 2016, 05:04 PM |
| Downing Philip A | VP, Preclinical Srvcs. | Sep 14, 2015 | Buy | $1.73 | 3,000 | 5,190 | 7,000 | Sep 16, 2015, 11:52 AM |
| Dougherty Connie Leigh | VP, Business Development | Aug 21, 2015 | Buy | $1.42 | 6,900 | 9,798 | 6,900 | Aug 25, 2015, 05:20 PM |
| Lemke Jacqueline M | President and CEO | Jun 18, 2015 | Option Exercise | $2.12 | 96,815 | 205,248 | 56,685 | Jun 22, 2015, 04:28 PM |
| Lemke Jacqueline M | President and CEO | Jun 18, 2015 | Option Exercise | $1.38 | 125,500 | 173,200 | 153,500 | Jun 22, 2015, 04:28 PM |
| Lemke Jacqueline M | President and CEO | Feb 27, 2015 | Buy | $2.04 | 3,000 | 6,120 | 3,000 | Mar 03, 2015, 06:30 PM |
| Lemke Jacqueline M | President and CEO | Feb 27, 2015 | Buy | $2.04 | 7,000 | 14,280 | 28,000 | Mar 03, 2015, 06:30 PM |
| Devine John P | VP--Toxicology | Aug 25, 2014 | Option Exercise | $1.01 | 2,500 | 2,525 | 2,500 | Aug 26, 2014, 04:17 PM |
| Devine John P | VP--Toxicology | Jun 13, 2014 | Sale | $2.64 | 3,130 | 8,263 | 0 | Jun 19, 2014, 04:57 PM |
| Devine John P | VP--Toxicology | Mar 03, 2014 | Option Exercise | $2.70 | 1,870 | 5,049 | 3,130 | Jun 17, 2014, 07:00 PM |
| Devine John P | VP--Toxicology | Mar 03, 2014 | Option Exercise | $1.01 | 5,000 | 5,050 | 5,000 | Jun 17, 2014, 07:00 PM |
| Devine John P | VP--Toxicology | Jun 13, 2014 | Sale | $2.64 | 3,130 | 8,263 | 0 | Jun 17, 2014, 07:00 PM |
| Johnson Richard Allen | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 10,000 | Aug 20, 2012, 06:07 PM |
| Sullivan A. Charlene | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 10,000 | Aug 20, 2012, 06:06 PM |
| Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP Fin | Aug 17, 2012 | Buy | $1.26 | 20,000 | 25,200 | 21,000 | Aug 20, 2012, 06:05 PM |
| CRABB DAVID W | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 11,300 | Aug 20, 2012, 06:04 PM |
| Landis John B. | Director | Aug 17, 2012 | Buy | $1.26 | 30,000 | 37,800 | 30,000 | Aug 20, 2012, 06:03 PM |
| Boulet Larry Steven | Director | Aug 17, 2012 | Buy | $1.26 | 11,500 | 14,490 | 15,000 | Aug 20, 2012, 06:02 PM |
| OMACHINSKI DAVID L | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 20,000 | Aug 20, 2012, 06:00 PM |
| OMACHINSKI DAVID L | Director | Sep 15, 2010 | Buy | $0.90 | 10,000 | 9,000 | 10,000 | Sep 16, 2010, 05:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Leasure Robert Jr. | President and CEO | 06/07/2019 | 14,864 |
| Garrett Michael | Chief Commercial Officer | 12/14/2023 | 14,145 |
| Beattie John Gregory | Chief Operating Officer | 12/14/2023 | 149,836 |
| Sagartz John E | Chief Strategy Officer | 03/14/2023 | 25,041 |
| Beattie John Gregory | Chief Operating Officer | 02/22/2023 | 34,950 |
| Pitchford William D | Chief Human Resources Officer | 12/09/2022 | 12,366 |
| Neff R Matthew | Director | 12/01/2022 | 6,120 |
| Neff R Matthew | Director | 11/01/2022 | 21,123 |
| Neff R Matthew | Director | 10/17/2022 | 19,100 |
| Garrett Michael | Chief Commercial Officer | 09/15/2022 | 23,058 |
| Beattie John Gregory | Chief Operating Officer | 09/09/2022 | 198,826 |
| Harkness James | Chief Operating Officer, RMS | 03/15/2022 | 765,637 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 02/22/2022 | 47,946 |
| Taylor Beth | VP- Finance & CFO | 02/18/2022 | 115,358 |
| Davis Gregory Cole | Director | 02/18/2022 | 86,214 |
| Davis Gregory Cole | Director | 02/17/2022 | 25,714 |
| Garrett Michael | Chief Commercial Officer | 02/18/2022 | 23,500 |
| Pitchford William D | Chief HR Officer | 02/18/2022 | 73,920 |
| Beattie John Gregory | Chief Operating Officer | 02/18/2022 | 23,879 |
| Beattie John Gregory | Chief Operating Officer | 02/17/2022 | 97,468 |
| Beattie John Gregory | Chief Operating Officer | 02/16/2022 | 137,524 |
| Leasure Robert Jr. | President and CEO | 02/17/2022 | 115,131 |
| Sagartz John E | Chief Strategy Officer | 02/17/2022 | 49,999 |
| Johnson Richard Allen | Director | 08/02/2021 | 32,300 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 12/22/2021 | 131,577 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 12/22/2021 | 131,577 |
| Sagartz John E | Chief Strategy Officer | 05/28/2021 | 49,857 |
| Sagartz John E | Chief Strategy Officer | 05/27/2021 | 120 |
| Taylor Beth | VP- Finance & CFO | 03/05/2021 | 88,500 |
| Beattie John Gregory | Chief Operating Officer | 03/01/2021 | 31,843 |
| Beattie John Gregory | Chief Operating Officer | 02/23/2021 | 116,032 |
| Leasure Robert Jr. | President and CEO | 02/24/2021 | 72,100 |
| Neff R Matthew | Director | 03/13/2020 | 13,166 |
| Neff R Matthew | Director | 03/12/2020 | 32,289 |
| Neff R Matthew | Director | 02/20/2020 | 43,507 |
| Sagartz John E | Chief Strategy Officer | 08/19/2020 | 17,732 |
| Neff R Matthew | Director | 08/19/2020 | 23,750 |
| Leasure Robert Jr. | President and CEO | 06/15/2020 | 14,997 |
| Pitchford William D | Chief HR Officer | 05/21/2020 | 44,700 |
| Taylor Beth | VP- Finance & CFO | 05/21/2020 | 14,916 |
| Taylor Beth | VP- Finance & CFO | 05/20/2020 | 21,804 |
| Taylor Beth | VP- Finance & CFO | 05/19/2020 | 22,193 |
| Leasure Robert Jr. | President and CEO | 03/16/2020 | 19,893 |
| Neff R Matthew | Director | 03/13/2020 | 13,166 |
| Neff R Matthew | Director | 03/12/2020 | 45,600 |
| Neff R Matthew | Director | 02/20/2020 | 43,507 |
| Johnson Richard Allen | Director | 02/20/2020 | 92,600 |
| Leasure Robert Jr. | President and CEO | 09/13/2019 | 99,867 |
| Oakley Daniel Thomas | Chief Operating Officer | 09/13/2019 | 3,650 |
| Pitchford William D | Chief HR Officer | 09/13/2019 | 44,400 |
| Perrow Wendy | Director | 09/10/2019 | 36,200 |
| Oakley Daniel Thomas | Chief Operating Officer | 09/06/2019 | 6,700 |
| Oakley Daniel Thomas | Chief Operating Officer | 09/05/2019 | 36,225 |
| Leasure Robert Jr. | President and CEO | 09/04/2019 | 36,225 |
| Oakley Daniel Thomas | Chief Operating Officer | 08/29/2019 | 13,450 |
| Oakley Daniel Thomas | Chief Operating Officer | 08/23/2019 | 7,185 |
| Leasure Robert Jr. | President and CEO | 08/19/2019 | 35,040 |
| Neff R Matthew | Director | 06/13/2019 | 2,792 |
| Leasure Robert Jr. | President and CEO | 06/12/2019 | 8 |
| Leasure Robert Jr. | President and CEO | 06/13/2019 | 9,850 |
| Oakley Daniel Thomas | Chief Operating Officer | 06/14/2019 | 14,925 |
| Blumhoff Jill | VP, Finance & CFO | 06/11/2019 | 990 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 06/10/2019 | 9,800 |
| Leasure Robert Jr. | President and CEO | 06/07/2019 | 9,800 |
| Leasure Robert Jr. | President and CEO | 06/06/2019 | 1,950 |
| Davis Gregory Cole | Director | 05/29/2019 | 9,950 |
| Davis Gregory Cole | Director | 05/31/2019 | 10,000 |
| Davis Gregory Cole | Director | 05/30/2019 | 9,800 |
| Oakley Daniel Thomas | Chief Operating Officer | 03/15/2019 | 2 |
| Sagartz John E | Director | 03/14/2019 | 2,716 |
| Leasure Robert Jr. | President and CEO | 03/12/2019 | 11,640 |
| Leasure Robert Jr. | President and CEO | 03/08/2019 | 7,080 |
| Neff R Matthew | Director | 03/08/2019 | 10,001 |
| Oakley Daniel Thomas | Chief Operating Officer | 03/06/2019 | 17,500 |
| Oakley Daniel Thomas | Chief Operating Officer | 03/01/2019 | 192 |
| Sagartz John E | Director | 02/19/2019 | 3,575 |
| Leasure Robert Jr. | President and CEO | 03/01/2019 | 16,200 |
| Leasure Robert Jr. | President and CEO | 02/28/2019 | 13,439 |
| Oakley Daniel Thomas | Chief Operating Officer | 02/27/2019 | 16,564 |
| KISSINGER PETER | 10% Owner | 09/14/2018 | 17,382 |
| Neff R Matthew | Director | 09/12/2018 | 4,125 |
| Neff R Matthew | Director | 09/14/2018 | 4,150 |
| Blumhoff Jill | VP, Finance & CFO | 09/13/2018 | 729 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 09/11/2018 | 8,350 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 02/16/2018 | 7,300 |
| Neff R Matthew | Director | 09/08/2017 | 7,500 |
| Davis Gregory Cole | Director | 08/18/2017 | 8,500 |
| Neff R Matthew | Director | 08/18/2017 | 8,500 |
| Blumhoff Jill | VP, Finance & CFO | 03/15/2017 | 2,721 |
| Blumhoff Jill | VP, Finance & CFO | 03/15/2017 | 2,720 |
| Downing Philip A | VP, Preclinical Srvcs. | 03/01/2017 | 10,101 |
| Downing Philip A | VP, Preclinical Srvcs. | 03/01/2017 | 10,100 |
| Dougherty Connie Leigh | VP, Business Development | 05/27/2016 | 389 |
| Dougherty Connie Leigh | VP, Business Development | 05/23/2016 | 88 |
| Dougherty Connie Leigh | VP, Business Development | 05/19/2016 | 1,523 |
| Lemke Jacqueline M | President and CEO | 02/29/2016 | 7,020 |
| Lemke Jacqueline M | President and CEO | 02/29/2016 | 4,742 |
| Downing Philip A | VP, Preclinical Srvcs. | 09/14/2015 | 5,190 |
| Dougherty Connie Leigh | VP, Business Development | 08/21/2015 | 9,798 |
| Lemke Jacqueline M | President and CEO | 06/18/2015 | 205,248 |
| Lemke Jacqueline M | President and CEO | 06/18/2015 | 173,200 |
| Lemke Jacqueline M | President and CEO | 02/27/2015 | 6,120 |
| Lemke Jacqueline M | President and CEO | 02/27/2015 | 14,280 |
| Devine John P | VP--Toxicology | 08/25/2014 | 2,525 |
| Devine John P | VP--Toxicology | 06/13/2014 | 8,263 |
| Devine John P | VP--Toxicology | 03/03/2014 | 5,049 |
| Devine John P | VP--Toxicology | 03/03/2014 | 5,050 |
| Devine John P | VP--Toxicology | 06/13/2014 | 8,263 |
| Johnson Richard Allen | Director | 08/17/2012 | 12,600 |
| Sullivan A. Charlene | Director | 08/17/2012 | 12,600 |
| Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP Fin | 08/17/2012 | 25,200 |
| CRABB DAVID W | Director | 08/17/2012 | 12,600 |
| Landis John B. | Director | 08/17/2012 | 37,800 |
| Boulet Larry Steven | Director | 08/17/2012 | 14,490 |
| OMACHINSKI DAVID L | Director | 08/17/2012 | 12,600 |
| OMACHINSKI DAVID L | Director | 09/15/2010 | 9,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN INOTIV INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 975,295 | 0.00672% | -18.49% | Event Driven |
| BLACKROCK INC. | 216,137 | 0.00002% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 192,297 | 0.00007% | 4.09% | Other |
| AQR CAPITAL MANAGEMENT LLC | 144,168 | 0.001% | -64.56% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 47,464 | 0.00027% | -13.01% | Other |
CHANGE IN SHARES OUTSTANDING FOR INOTIV INC
STOCK BUYBACKS FOR INOTIV INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.06%
1Q
06/30/2023
-0.99%
2Q
03/31/2023
0.30%
3Q
12/31/2022
0.63%
4Q
09/30/2022
0.63%
5Q
06/30/2022
1.00%
6Q
03/31/2022
1.77%
7Q
12/31/2021
21.97%
8Q
09/30/2021
55.06%
9Q
06/30/2021
67.48%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INOTIV INC
LOADING...